Voyager Therapeutics, Inc.’s Post

Tucson Biotech Bikeride #2! Iman Daryaei, Ph.D., Martin Fuchs, Peter Nestler, and Zachary S. Brooks, PhD, EMBA from TheraCea Pharma Metfora Biodarix Lifesciences LLC UGenome Biotech braved 35 degrees F (2 degrees C) weather for the second Tucson Biotech Bike Ride #2! The next ride will take place on January 13, 2024. Richard Austin, Michael Abrahamson, Jen Watson Koevary, Jordan Lancaster, Tripp Shannon, CFA, William Wimmer, Scott Zentack, CFA, Kenneth Fox, Julian Dresler, and others are invited representing Reglagene, Avery Therapeutics, Inc. Palo Verde Clinical Research #ugenome ,#ugenomebiotech ,#bioinformatics ,#biotechnology ,#reglagene,#biotech ,#genetics ,#science ,#metfora,#research ,#genomics ,#medicine ,#theracea,#drugdiscovery,, ,#PaloVerdeClinicalResearch, #UArizona,#TLA,#datascience, #lifesciences ,#biostatistics ,#health ,#chemistry, ,#pharma, #pharmacogenomics, #pharmacogenetics,#genomicmedicine, #sequencing,#dataanalysis, #machinelearning, #precisionmedicine,

If you're in the One Kendall Square, Cambridge area, don't miss our tabletop at the BVS event. Meet Jiyao (Ella) Zhang, our experienced PhD-level expert, and discover how iXCells products and services can support your research and discovery needs. #CellTechnology #GeneTherapy #CellTherapy #Innovation #DrugDiscovery #PersonalizedMedicine #RareDiseases #GeneEditing #EngineeredCells #CRISPRCas9 #CellModels #STEMCells #Biotechnology #LifeSciences #ResearchandDevelopment #motorneurons #immunecells #immunooncology #preclinicalservices #biotechevents

Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting To learn more, please visit: https://ow.ly/kqpN50SqOz8 $ENSC #biosciences #nextgenerationopioids

Take two minutes to watch our teaser trailer to learn more about how BigHat Biosciences uses AI/ML and synthetic biology to develop better antibodies faster.

👀 Peek into Element Biosciences's AVITI at the Garvan Institute of Medical Research – first site in the Southern Hemisphere. Many thanks go to all involved in planning, delivery, installation Mike Marshall Bobby Nasr and training Marty Flores.   🎯 This Out-of-the-box system has a dual flow cell design and individually addressable lanes, allowing the flexibility for operating two separate sequencing runs in one system.  🎯 Together with Element’s proprietary avidity base chemistry (ABC) 🔤 , the AVITI enables exceptional accuracy (>90% >Q30) and reduced reagent consumption, delivering higher quality data and more cost-effective sequencing options. ℹLearn more about AVITI – https://lnkd.in/gjfHgHD5 ℹCheck out our press release if you missed it – https://lnkd.in/gz7RjMrV #AVITI #AVITILT #biotech #BioTechnology #DNASequencing #ElemBio #Genomics #RNASequencing #Sequencing

🔔 Final day alert! #ARVO2024 is wrapping up, but there's still time to connect with us at booth 1410! Don't miss the chance to meet our experts Reza Rezaei, DVM, PhD, MBA (VP), and Joseph Wekselblatt (Senior Scientist), and explore the latest in vision research. Feel free to contact us if you would like the poster.. See you there! 🌟 #arvo #sciencematters #ophthalmology #preclinicalresearch #preclinical #cro #visioncare #biotech #bioscience #biotechnology

In Episode 2 of our new video series, find out more about how SEPPIC's two biotechnologies Celtosome™ and Celebrity™ work. Watch it now and stay tuned for the last one! 🎬 #biotechnologies #cosmetics #cosmeticingredients

It was a thrill to ride today with Iman Daryaei, Ph.D., Martin Fuchs, Peter Nestler, and Marco Schito from TheraCea Pharma, Metfora, Biodarix Lifesciences LLC, and Critical Path Institute (C-Path) and of course UGenome AI. #ugenome, #ugenomeai, #pharmacogenomics, #pharmacogenetics, #bioinformatics, #genetics, #dna, #research, #genomics, #medicine, #drugdiscovery, #datascience, #biostatistics, #pharma, #genomicmedicine, #sequencing, #dataanalysis, #precisionmedicine

BATM Advanced Communications Ltd (LSE:BVC) is taking good strides forward as evidenced by today’s investment in ADOR Diagnostics, according to house broker Shore Capital. Ador is a molecular diagnostics company developing the disruptive NATlab molecular biology platform, notes the broker. NATlab uses novel diagnostic technologies in its multiplex solution, with a  focus on infectious diseases. ADOR has had 11 patents issued in the US and eight internationally with others pending. ShoreCap adds that strong underlying progress is being delivered across the development of BATM’s core span of technologies.  “These are visibly moving towards potential market inflexion points, thus presenting a profitable high-growth opportunity to investors.”  Asset allocation, with business strategy, is firmly focused on growth investment.  More at #Proactive #ProactiveInvestors http://ow.ly/Rotr104YL53 #LSE #BVC

Strive to minimize the impact on biodiversity while crafting ingredients with proven efficacy. Watch Seppic's video to learn more about their two innovative ingredients and redefine what's possible! #personalcare #biotechnology #cosmeticingredients